Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial

BACKGROUND: There is high medical need for safe long-term immunosuppression monotherapy in kidney transplantation. Selective targeting of post-transplant alloantigen-(re)activated effector-T cells by anti-TNF antibodies after global T cell depletion may allow safe drug minimization, however, it is u...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Viklicky, Ondrej, Hruba, Petra, Tomiuk, Stefan, Schmitz, Sabrina, Gerstmayer, Bernhard, Sawitzki, Birgit, Miqueu, Patrick, Mrazova, Petra, Tycova, Irena, Svobodova, Eva, Honsova, Eva, Janssen, Uwe, Volk, Hans-Dieter, Reinke, Petra
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5234822/
https://ncbi.nlm.nih.gov/pubmed/28085915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0169624
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak